Treatment of therapy-resistant sarcoidosis with adalimumab

Clinical Rheumatology

Volumn 25, Issue 4, 2006, Pages 596-597

  Callejas Rubio, José Luis ^a   Ortego Centeno, Norberto ^a   Lopez Perez, Lourdes ^a   Benticuaga, Maria Nicolas ^a  

^a NONE   (Spain)

Author keywords

Adalimumab; Etanercept; Infliximab; Sarcoidosis

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; ETANERCEPT; GALLIUM 67; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN AMERICAN; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DYSPNEA; FIBEROPTIC BRONCHOSCOPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LUNG HILUS; LUNG SCINTISCANNING; LYMPHADENOPATHY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; SARCOIDOSIS; THORACOCENTESIS; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DIABETES MELLITUS, TYPE 1; DRUG RESISTANCE; HUMANS; MALE; SARCOIDOSIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746557415     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0037-9     Document Type: Article

References (9)

1. Seitzer U, Swider C, Stüber F, Suchnicki K, Lange A, Ritcher E et al (1997) Tumour necrosis factor α promoter gene polymorphism in sarcoidosis. Cytokine 9:787-790
2. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E et al (2001) Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology. Infect Immun 69:1847-1855
3. Yee AMF, Pochapin MB (2001) Treatment of complicated sarcoidosis wit infliximab anti-tumor necrosis factor-α therapy. Ann Intern Med 135:27-31
4. Baughman RP, Lower EF (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70-74
5. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vulk-Pavlovic Z et al (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124:177-185
6. Ulbritcht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor α blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542-3543
7. Ali Y, Perlman E (2004) Successful treatment of sarcoidosis. Ann Intern Med 140:48
8. Thumfart J, Müller D, Rudolph B, Zimmering M, Querfeld U, Haffner D (2004) Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy. Am J Kidney Dis 45:411-414
9. Baker DE (2004) Adalimumab: Human recombinant immunoglobulin G1 anti-tumor necrosis factor monoclonal antibody. Rev Gastroenterol Disord 4:196-210